Our Team

 

Executive Team

Miriam Cremer

Miriam Cremer

President/Founder

Eveline Mumenthaler

Eveline Mumenthaler

Chief Operating Officer

Rachel Masch

Rachel Masch

Chief Medical Officer

Karla Alfaro

Karla Alfaro

Medical Director

Administrative and Finance Team

Ivonne Alfaro

Ivonne Alfaro

Accounting Assistant

Andrew Gray

Andrew Gray

Program and Operations Manager

Violeta Hernandez

Violeta Hernandez

Accounting and Finance Admin

Evelyn Rodas

Evelyn Rodas

Administrative Analyst

IT Team

René Novoa

René Novoa

IT Manager

Program Operations

Alexander Alvarado

Alexander Alvarado

Molecular Biology Coordinator

Norma Alvarado

Norma Alvarado

Nurse

Javier Ayala

Javier Ayala

Program Supervisor

Alvaro Dono

Alvaro Dono

Driver

Ambrosio Duran

Ambrosio Duran

Driver

Tania Escobar

Tania Escobar

Nurse

Monica Estrada

Monica Estrada

Nurse

Julio Flores

Julio Flores

Driver

Jasmin Franco

Jasmin Franco

Nurse

Katia Guevara

Katia Guevara

Data Entry Assistant

Denise Lopez

Denise Lopez

Data Entry Assistant

Leticia Lopez

Leticia Lopez

Program Supervisor

Manuel Lopez

Manuel Lopez

Driver

Vilma Maravilla

Vilma Maravilla

Nurse

Eunice Mayen

Eunice Mayen

Nurse

Larissa Melendez

Larissa Melendez

Nurse

Fredy Mendez

Fredy Mendez

Program Supervisor

Carlos Perez

Carlos Perez

Driver

Jose Roberto Perez

Jose Roberto Perez

Program Supervisor

Juan Carlos Rauda

Juan Carlos Rauda

Program Supervisor

Marina Rivas

Marina Rivas

Nurse

Gladys Sanchez

Gladys Sanchez

Nurse

Elizabeth Torres

Elizabeth Torres

Training and Clinical Coordinator

Karla Vasquez

Karla Vasquez

Nurse

Operations

Rene Alvarez

Rene Alvarez

Maintenance

Dagoberto Mendoza

Dagoberto Mendoza

Security

Ester Solis

Ester Solis

Custodian

1. Scientific & Academic Research


We conduct rigorous scientific and academic research to test, validate, and refine novel cervical cancer prevention strategies. Our research focuses on identifying approaches that improve early detection and treatment while remaining feasible in real-world health systems.

This includes:

  • Evaluating high-performance HPV screening technologies
  • Studying self-collection and alternative screening models to reach under-screened populations
  • Generating evidence to inform national and global policy decisions

By partnering with academic institutions, ministries of health, and clinical researchers, we ensure that our findings contribute to the global evidence base and directly inform practice.

This will close in 0 seconds